IMMUNOCORE HLDGS ADS/1 Long-term Investment Intensity
IMMUNOCORE HLDGS ADS/1 long-term investment intensity. IMMUNOCORE HLDGS ADS/1 (6YG) has a Long-term Investment Intensity of 0.0% as of December 2022. Long-term investments of €137.00K represent 0.0% of total assets of €526.76 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read IMMUNOCORE HLDGS ADS/1 (6YG) financial obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of IMMUNOCORE HLDGS ADS/1 (2022–2022)
Long-term investment intensity of IMMUNOCORE HLDGS ADS/1 from 2022 to 2022. This chart shows how IMMUNOCORE HLDGS ADS/1's Long-term Investment Intensity has evolved across 1 annual periods from 2022 to 2022. As of December 2022, the intensity stands at 0.0%, reflecting long-term investments of €137.00K against total assets of €526.76 Million EUR.
IMMUNOCORE HLDGS ADS/1 Long-term Investment Intensity by Year (2022–2022)
IMMUNOCORE HLDGS ADS/1 long-term investment intensity by year from 2022 to 2022. The table below presents the year-by-year Long-term Investment Intensity for IMMUNOCORE HLDGS ADS/1 from 2022 to 2022, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 6YG total asset value.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 0.0% | €137.00K | €526.76 Million | — |